aripiprazole;sertraline
- Generic Name
- aripiprazole;sertraline
Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults
Phase 1
Completed
- Conditions
- Healthy Male Adults
- Interventions
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2021-05-03
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 74
- Registration Number
- NCT03342963
- Locations
- 🇯🇵
Clinic of Kyusyu Region, Fukuoka, Japan
A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT02088697
- Locations
- 🇯🇵
Osaka Pharmacology Clinical research Hospital, Osaka, Japan
Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
- First Posted Date
- 2014-01-28
- Last Posted Date
- 2018-05-21
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 412
- Registration Number
- NCT02046564
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath